研究显示,首尔伟傲世的Violeds技术可在不到1秒内杀灭99%的冠状病毒(SARS-CoV-2)

2021-01-14 国际文传 国际文传

首尔伟傲世(KOSDAQ: 092190),领先的化合物半导体解决方案提供商,Violeds技术仅需1秒钟时间即能迅速有效地杀灭99.437%的SARS-CoV-2。

首尔伟傲世(KOSDAQ: 092190),领先的化合物半导体解决方案提供商,Violeds技术仅需1秒钟时间即能迅速有效地杀灭99.437%的SARS-CoV-2。该测试是于2020年12月通过KR Biotech进行的,这家总部位于韩国的研究所专业从事新型冠状病毒的消毒测试。

测试结果表明,Violeds技术可能是对空气传播病毒、供水系统、COVID-19患者出没区域甚至医院病房进行消毒的有效方法。

研究小组观察SARS-CoV-2分别暴露于采用Violeds技术的UV LED模块1、3和5秒后的灭活率。测试结果显示,Violeds在1秒内的灭活率高达99.437%。

Violeds是一种先进的化合物半导体技术,是替代传统UV灯泡的更安全、有经济优势的解决方案。传统UV灯泡含有汞,当灯泡损坏时,汞不会溶解,可在人体内蓄积,且UV灯泡寿命短,只有约5千小时,因此需要定期更换。而UV LED技术具有成本和安全性的优势,寿命长达5万小时,是汞灯泡寿命的10倍以上。

此外,由于技术进步,如小于1毫米的小型化和更高的能效,UV LED市场正在迅速取代价值7千万美元的UV汞灯泡市场。据市场调研公司Yole Développement预计,随着UV LED技术被用于生物保健和病毒消毒的新行业所采用,到2025年UV LED的全球市场将增至27.86亿美元。

Violeds,安全的UV光

1.

轻薄、紧凑,尺寸小于1平方毫米,其优化设计可完全阻断UV暴露。

2.

UV光检测传感器是首尔伟傲世开发的一种安全器件,用户能用其检查有无正常运行和UV泄漏。

3.

能将每日暴露量完全控制在国际安全标准允许范围内。

4.

由于UV光不包含有害化学物质,因此无需担心二次或三次损害,例如加湿器消毒剂导致的死亡。

首尔伟傲世的一位官员表示:“COVID-19大流行和病毒变异的风险仍在继续,尽管有接种流感疫苗,但美国年均流感死亡人数仍超过1万人。随着全球数以亿计的人暴露于各种疾病,预防病毒感染现在变得至关重要。因此,由于化学方法的危害,专业设计的UV LED消毒系统将来可能是更安全的解决方案和世界标准。”

http://www.businesswirechina.com/files/news/52357932-1610533128-1.jpg

KR Biotech对首尔伟傲世的UV LED Violeds的测试报告和结果

关于首尔伟傲世
首尔伟傲世是UV LED、VCSEL(垂直腔面发射激光)、新一代3D传感器和激光光源、以及用于显示的单像素RGB“微清洁像素”的全系列解决方案提供商。公司成立于2002年,是首尔半导体公司的子公司,在UV LED行业占据了第一的市场份额(LEDinside, 2018)。首尔伟傲世拥有全面的LED产品组合,包括所有波长范围(200nm到1600nm)的紫外线(UV)、可见光和红外线。它拥有超过4000项的UV LED技术相关的专利。Violeds是其旗舰产品UV LED技术,为众多行业提供了杀菌和消毒(UVC)、皮肤治疗(UVB)、水/空气净化和园艺有效栽培的解决方案。2018年,首尔伟傲世收购了光电专家RayCan公司,添加了先进的VCSEL技术,支持智能手机面部识别和自动驾驶,并已开始量产。在2020年1月,它推出了一款颠覆性的“微清洁像素”,有可能成为显示屏市场的游戏规则改变者。

原文阅读:http://www.businesswirechina.com/zh/news/45483.html

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-11-06 hukaixun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-06-22 江川靖瑶
  3. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-16 小刀医生
  4. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 Jassion

    消毒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1937983, encodeId=50a4193e98317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Nov 06 12:18:19 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005889, encodeId=4cd22005889ac, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Tue Jun 22 09:18:19 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321249, encodeId=1f0713212493d, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 16 07:18:19 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916573, encodeId=124e9165e35f, content=消毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/fe3c80d232384930a546a36ee78cff4f/d82eb5cea72846f695693a6725821ef1.jpg, createdBy=882d5440831, createdName=Jassion, createdTime=Thu Jan 14 16:43:58 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916552, encodeId=019a9165524a, content=<a href='/topic/show?id=859a1041322e' target=_blank style='color:#2F92EE;'>#Violeds技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104132, encryptionId=859a1041322e, topicName=Violeds技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:52 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916550, encodeId=04109165507b, content=<a href='/topic/show?id=466e159032f' target=_blank style='color:#2F92EE;'>#SARS-COV-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15903, encryptionId=466e159032f, topicName=SARS-COV-2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Jan 14 16:20:16 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

相关资讯

NEJM:洗必泰以及莫匹罗嗪日常消毒可降低耐甲氧西林金黄色葡萄球菌感染复发风险

研究认为,因耐甲氧西林金黄色葡萄球菌感染住院人群在出院后接受洗必泰以及莫匹罗嗪日常消毒可降低30%的感染复发风险

消毒“神药”生意经

来自中国的「皮肤神药」差点就逐渐征服欧洲人民了,直到英国药品与保健品管理机构(MHRA)发现了猫腻。2018年2月,MHRA检测出,一种在卖场打着「天然」标签的热销草药乳膏「YiganerjingCream」(一干二净)添加了多种激素。MHRA通告说,「一干二净」不是一款经过认证的药物,要求商店下架禁售,鼓励消费者举报,势要一干二净地清理「一干二净」。但这一愿景在2018年底被迫变化,MHRA

迎合机遇,深耕760亿元市场!《第三方消毒供应中心专题报告》在沪发布

2019年4月16日,由动脉网举办的VB100发布日活动,在上海临港浦江科技广场举行。会上,动脉网·蛋壳研究院重磅发布了《第三方消毒供应中心专题报告》。活动现场,作为产业的重要参与者和推动者,聚力康总经理徐晶上台致辞。聚力康成立于2010年,作为国内第三方消毒供应领跑者,已在7个城市建立业务,已运营中心共8家,连接了超过200家医院,为医院降低20-30%的消毒供应中心运行成本,服务合同每年复

Infec Cont Hosp Ep :手术室麻醉区的感染防控

目前越来越多的文献显示,麻醉工作区域的污染对病原菌传播的贡献越来越大,包括麻醉治疗车、输液连接管、喉镜、触摸屏、键盘以及麻醉医师手在内的区域和环节,可以影响医院感染的发生。例如麻醉师对多名患者使用同一药瓶的注射药液,患者护理不戴手套,手卫生依从性低等。

患者可能感染艾滋病 医疗器械消毒问题不是小事

口腔医疗是指运用药物、医疗器械等医疗工具为口腔病患者和美牙需求者提供诸如种植、正畸、修复、美白等医疗服务。近几年口腔医疗市场增速加快,目前国内口腔疾病患者数量超6亿,接受过治疗的仅有0.32亿人,潜在需求逐渐显现,口腔医疗行业的发展进入黄金市场,其医疗纠纷的预防和处理不容忽视,由于口腔的诊疗需要用到各种医疗器械,因此其所涉及的医疗纠纷有着自身的特点。本文就结合上述两个案例,从口腔诊疗所涉及的医疗器

拓展阅读

卫生部关于印发《预防与控制医院感染行动计划(2012-2015年)》通知

  卫医政发〔2012〕63号   各省、自治区、直辖市卫生厅局,新疆生产建设兵团卫生局:   预防和控制医院感染对保障医疗质量和医疗安全具有重要意义。为切实维护广大人民群众身体健康与生命安全,进一步加强医院感染预防与控制工作,提高医疗质量,保障医疗安全,根据“十二五”卫生事业发展规划和《医院感染管理办法》等,结合当前我国医院感染预防与控制工作现状,我部组织制定了《预防与控制医院感染行动计划(

2015年三级医院新生儿室需达到国标

  医院感染的预防与控制是保证医疗质量和医疗安全的重要工作。为切实维护广大人民群众身体健康与生命安全,卫生部昨天发布《预防与控制医院感染行动计划(2012—2015年)》(以下简称《行动计划》)。   《行动计划》指出,到2015年,建立符合我国国情的医院感染监控体系,初步形成国家、省级、医疗机构三级医院感染监控网络。   此外,到2015年,100%的三级医院、60%的地市级二级医院和30%